131 related articles for article (PubMed ID: 7899230)
1. The effect of cyclodextrins on the stability of peptides in nasal enzymic systems.
Irwin WJ; Dwivedi AK; Holbrook PA; Dey MJ
Pharm Res; 1994 Dec; 11(12):1698-703. PubMed ID: 7899230
[TBL] [Abstract][Full Text] [Related]
2. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
Friedman DI; Amidon GL
Pharm Res; 1991 Jan; 8(1):93-6. PubMed ID: 2014216
[TBL] [Abstract][Full Text] [Related]
3. An in vitro evaluation of metabolism and poor membrane permeation impeding intestinal absorption of leucine enkephalin, and methods to increase absorption.
Aungst BJ; Blake JA; Hussain MA
J Pharmacol Exp Ther; 1991 Oct; 259(1):139-45. PubMed ID: 1920113
[TBL] [Abstract][Full Text] [Related]
4. Transdermal delivery of bioactive peptides: the effect of n-decylmethyl sulfoxide, pH, and inhibitors on enkephalin metabolism and transport.
Choi HK; Flynn GL; Amidon GL
Pharm Res; 1990 Nov; 7(11):1099-106. PubMed ID: 2293206
[TBL] [Abstract][Full Text] [Related]
5. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.
Hussain MA; Koval CA; Shenvi AB; Aungst BJ
J Pharm Sci; 1990 May; 79(5):398-400. PubMed ID: 2352157
[TBL] [Abstract][Full Text] [Related]
6. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
Zhang Y; Jiang XG; Yao J
Acta Pharmacol Sin; 2001 Nov; 22(11):1051-6. PubMed ID: 11749800
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.
Shao Z; Krishnamoorthy R; Mitra AK
Pharm Res; 1992 Sep; 9(9):1157-63. PubMed ID: 1409397
[TBL] [Abstract][Full Text] [Related]
8. Hydrolysis of leucine enkephalin in the nasal cavity of the rat--a possible factor in the low bioavailability of nasally administered peptides.
Hussain A; Faraj J; Aramaki Y; Truelove JE
Biochem Biophys Res Commun; 1985 Dec; 133(3):923-8. PubMed ID: 4084310
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human nasal primary culture systems to investigate peptide metabolism.
Hoang VD; Uchenna AR; Mark J; Renaat K; Norbert V
Int J Pharm; 2002 May; 238(1-2):247-56. PubMed ID: 11996828
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Sinswat P; Tengamnuay P
Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
[TBL] [Abstract][Full Text] [Related]
11. Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery.
Cros CD; Toth I; Blanchfield JT
Bioorg Med Chem; 2011 Feb; 19(4):1528-34. PubMed ID: 21273080
[TBL] [Abstract][Full Text] [Related]
12. Nasal delivery of polypeptides I: nasal absorption of enkephalins in rats.
Su KS; Campanale KM; Mendelsohn LG; Kerchner GA; Gries CL
J Pharm Sci; 1985 Apr; 74(4):394-8. PubMed ID: 3889275
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin.
Bernkop-Schnürch A; Obermair K; Greimel A; Palmberger TF
Amino Acids; 2006 Jun; 30(4):417-23. PubMed ID: 16554973
[TBL] [Abstract][Full Text] [Related]
14. Nasal mucosal metabolism and absorption of pentapeptide enkephalin analogs having varying N-terminal amino acids.
Hussain MA; Seetharam R; Wilk RR; Aungst BJ; Kettner CA
J Pharm Sci; 1995 Jan; 84(1):62-4. PubMed ID: 7714746
[TBL] [Abstract][Full Text] [Related]
15. Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats.
Matsubara K; Abe K; Irie T; Uekama K
J Pharm Sci; 1995 Nov; 84(11):1295-300. PubMed ID: 8587046
[TBL] [Abstract][Full Text] [Related]
16. Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.
Hermens WA; Deurloo MJ; Romeyn SG; Verhoef JC; Merkus FW
Pharm Res; 1990 May; 7(5):500-3. PubMed ID: 2367318
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of nasal absorption of drugs. III: Nasal absorption of leucine enkephalin.
Faraj JA; Hussain AA; Aramaki Y; Iseki K; Kagoshima M; Dittert LW
J Pharm Sci; 1990 Aug; 79(8):698-702. PubMed ID: 2231332
[TBL] [Abstract][Full Text] [Related]
18. The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption.
Hussain MA; Shenvi AB; Rowe SM; Shefter E
Pharm Res; 1989 Feb; 6(2):186-9. PubMed ID: 2788271
[TBL] [Abstract][Full Text] [Related]
19. Study of nasal enzyme activity towards insulin. In vitro.
Gizurarson S; Bechgaard E
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2155-7. PubMed ID: 1797441
[TBL] [Abstract][Full Text] [Related]
20. Unidirectional uptake of enkephalins at the blood-tissue interface of the blood-cerebrospinal fluid barrier: a saturable mechanism.
Zlokovic BV; Segal MB; Davson H; Mitrovic DM
Regul Pept; 1988 Jan; 20(1):33-44. PubMed ID: 3127863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
